Conference Highlights: ASTRO 2019 – Article 4

Jan 17, 2020

Contributor: Mahmoud Barbarawi, MD

New research was presented at ASTRO 2019, American Society for Radiation Oncology Annual Meeting, from Sept. 15-18 in Chicago.

Author

Janine Anthes

View all posts

About The Expert

Janine Anthes

Mahmoud Barbarawi, MD
Academic Research Chief Resident
Department of Internal Medicine
Hurley Medical Center
Michigan State University

Mahmoud Barbarawi, MD, has indicated to Physician’s Weekly that he has no financial disclosures relevant to this article to report.

References

Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D supplementation and cardiovascular disease risks in more than 83 000 individuals in 21 randomized clinical trials: a meta-analysis. JAMA Cardiol. 2019 Jun 19 [Epub ahead of print]. Available at: https://jamanetwork.com/journals/jamacardiology/fullarticle/2735646.

Scragg R, Stewart AW,Waayer D, et al. Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial. JAMA Cardiol. 2017;2(6):608-616.

Pekkanen MP, Ukkola O, Hedberg P, et al. Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease. Nutr Metab Cardiovasc Dis. 2015;25(5):471-478.

LeFevre ML; U.S. Preventive Services Task Force. Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015;162(2):133-140.

Follow Us

Conference Highlights: ASTRO 2019 – Article 4

Contributor: Mahmoud Barbarawi, MD

Author

About The Expert

References